Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Veeva Systems Inc (VEEV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,968,411
  • Shares Outstanding, K 143,440
  • Annual Sales, $ 685,571 K
  • Annual Income, $ 141,966 K
  • 36-Month Beta 1.65
  • Price/Sales 18.84
  • Price/Cash Flow 80.74
  • Price/Book 11.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/19
See More
  • Average Estimate 0.31
  • Number of Estimates 8
  • High Estimate 0.32
  • Low Estimate 0.30
  • Prior Year 0.17
  • Growth Rate Est. (year over year) +82.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.61 +15.97%
on 11/20/18
101.39 -8.95%
on 11/29/18
+2.60 (+2.90%)
since 11/12/18
3-Month
79.61 +15.97%
on 11/20/18
109.05 -15.34%
on 09/28/18
-12.29 (-11.75%)
since 09/12/18
52-Week
52.17 +76.96%
on 02/09/18
109.05 -15.34%
on 09/28/18
+36.45 (+65.24%)
since 12/12/17

Most Recent Stories

More News
CVS Health Aetna Synergy Impressive, PBM Selling Season Solid

CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.

CVS : 74.67 (+1.72%)
ITGR : 85.69 (+1.98%)
SRDX : 59.58 (+1.78%)
VEEV : 92.84 (+2.69%)
STERIS Rides on Favorable Industry Trends, Rivalry a Concern

STERIS (STE) is currently displaying strong top-line growth on encouraging market trends along with a new product and service portfolio.

ITGR : 85.69 (+1.98%)
SRDX : 59.58 (+1.78%)
STE : 118.29 (+3.26%)
VEEV : 92.84 (+2.69%)
NuVasive's Monolith Corpectomy System Ok'd for Expanded Use

NuVasive's (NUVA) latest FDA 510 (k) clearance receipt is expected to augment customer base and market reach.

ITGR : 85.69 (+1.98%)
SRDX : 59.58 (+1.78%)
NUVA : 56.89 (+0.49%)
VEEV : 92.84 (+2.69%)
Hologic Unveils Omni Hysteroscope, Boosts GYN Surgical Arm

Hologic (HOLX) highlights that a direct visualization of the uterine cavity in women with abnormal uterine bleeding will set a benchmark for the medical test.

HOLX : 43.41 (+2.29%)
ITGR : 85.69 (+1.98%)
SRDX : 59.58 (+1.78%)
VEEV : 92.84 (+2.69%)
Hill-Rom Adds New Capabilities to Centrella Smart+ Beds

Hill-Rom (HRC) stays focused on expansion through product development. The latest move is expected to boost the top-line results of the company.

ITGR : 85.69 (+1.98%)
SRDX : 59.58 (+1.78%)
VEEV : 92.84 (+2.69%)
HRC : 97.26 (+3.49%)
Here's Why You Should Buy Myriad Genetics (MYGN) Stock Now

Myriad Genetics (MYGN) see strong testing volumes from new products.

ITGR : 85.69 (+1.98%)
SRDX : 59.58 (+1.78%)
MYGN : 31.73 (+3.05%)
VEEV : 92.84 (+2.69%)
Insulet Gains on Omnipod Reimbursement Update, Rivalry Stiff

Insulet Corporation (PODD) continues to expand Omnipod's market access on growing reimbursements. The company operates in a highly competitive environment.

ITGR : 85.69 (+1.98%)
VEEV : 92.84 (+2.69%)
PODD : 83.78 (+1.56%)
MDT : 96.74 (+1.33%)
Myriad Genetics Announces Encouraging EndoPredict Test Data

Myriad Genetics (MYGN) forges ahead with initiatives to boost the adoption of the EndoPredict tests.

ITGR : 85.69 (+1.98%)
DGX : 88.97 (+0.99%)
MYGN : 31.73 (+3.05%)
VEEV : 92.84 (+2.69%)
Illumina (ILMN) Takes Part in NIH Program With Genotype Launch

The new Infinium Global Diversity Array of Illumina (ILMN) will process up to 1 million cost-free samples to the three genome centers.

ITGR : 85.69 (+1.98%)
SRDX : 59.58 (+1.78%)
ILMN : 341.32 (+3.78%)
VEEV : 92.84 (+2.69%)
Time to Focus on Veeva Systems (VEEV) for Strong Earnings Growth Potential

Veeva Systems (VEEV) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

VEEV : 92.84 (+2.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade VEEV with:

Business Summary

Veeva Systems Inc. operates as a provider of industry-specific, cloud-based software solutions for the life sciences industry. It offers enterprise applications, a multichannel platform, customer relationship management, and content management solutions. The Company provides its solutions to pharmaceutical,...

See More

Key Turning Points

2nd Resistance Point 94.43
1st Resistance Point 92.42
Last Price 92.84
1st Support Level 88.98
2nd Support Level 87.55

See More

52-Week High 109.05
Last Price 92.84
Fibonacci 61.8% 87.32
Fibonacci 50% 80.61
Fibonacci 38.2% 73.90
52-Week Low 52.17

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar